Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Endometrial glandular epithelial cell exosomes are small extracellular vesicles (typically 30–150 nm in diameter) secreted by the glandular epithelial cells of the endometrium. These exosomes play a crucial role in intercellular communication within the uterine environment, particularly during processes such as embryo implantation and tissue regeneration. They carry proteins, lipids, mRNAs, and microRNAs that can modulate recipient cell behavior. Research has shown that these exosomes can promote proliferation of human endometrial glandular cells and facilitate trophoblast invasion during embryo implantation by reprogramming target cell proteomes through pathways involving focal adhesion molecules and kinases like MAPK3[1][2][5]. Additionally, they have been investigated for their therapeutic potential in conditions such as intrauterine adhesions (IUA) and endometriosis due to their ability to modulate fibrosis markers (e.g., Vimentin, COL5A2, COL1A1) and influence immune responses[1][6]. Currently, their use is primarily experimental or investigational.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on endometrial glandular epithelial cell exosomes.